Near-infrared fluorescence imaging with indocyanine green for assessment of donor livers in a rat model of ischemia–reperfusion

Table 2 Effect of different ischemia times on liver function (mean ± SD)

Liver function	Control	Group		POD 1	POD 7
ALT (U/L)	83.26 ± 10.31	A	I	116.28 ± 14.43	84.34 ± 5.58
		A	II	158.57 ± 26.48	73.22 ± 8.55
		B	III	267.64 ± 39.82^a	56.27 ± 5.32^a
			IV	345.47 ± 28.92^b	74.08 ± 18.04^a
			V	418.18 ± 17.31^b	59.46 ± 3.68^a
		C	VI	2038.33 ± 114.80^c	90.51 ± 18.41^c
		C	VII	2585.46 ± 99.56^d	104.40 ± 8.00^c
AST (U/L)	163.92 ± 40.72	A	I	348.49 ± 34.50	121.99 ± 10.10
		A	II	346.23 ± 36.88	129.85 ± 13.96
		B	III	587.63 ± 16.13^b	114.34 ± 12.22
			IV	652.02 ± 34.83^b	124.29 ± 9.84
			V	1000.94 ± 77.29^b	140.45 ± 21.18
		C	VI	2163.72 ± 33.70^d	222.83 ± 23.62^c
		C	VII	2794.61 ± 177.41^d	239.03 ± 44.12^c
DB (µmol/L)	3.38 ± 0.92	A	I	3.40 ± 0.51	2.74 ± 0.50
		A	II	4.01 ± 0.20	2.82 ± 0.15
		B	III	4.88 ± 0.52	3.28 ± 0.11^a
			IV	4.91 ± 0.08	3.33 ± 0.15^a
			V	4.96 ± 0.35	3.62 ± 0.06^b
		C	VI	4.92 ± 0.25	4.14 ± 0.24^c
		C	VII	5.35 ± 0.63	4.99 ± 0.03^d
TB (µmol/L)	9.51 ± 0.29	A	I	8.43 ± 1.20	8.43 ± 1.20
		A	II	6.98 ± 0.03	7.02 ± 0.12
		B	III	10.75 ± 0.44^b	7.73 ± 0.24
			IV	9.13 ± 1.00^b	9.26 ± 0.23^b
			V	8.51 ± 0.29^b	9.47 ± 0.44
		C	VI	11.44 ± 0.21^d	10.79 ± 0.92^c
		C	VII	12.50 ± 0.19^d	12.06 ± 0.35^c
LDH (U/L)	733.18 ± 102.0	A	I	1421.22 ± 276.70	590.93 ± 14.68
		A	II	1452.79 ± 324.34	736.05 ± 146.78
		B	III	2341.30 ± 105.82	939.20 ± 43.17
			IV	1471.21 ± 81.76	725.76 ± 154.91
			V	1549.70 ± 163.10	953.03 ± 78.40
		C	VI	1562.79 ± 55.89	1889.12 ± 96.55^d
		C	VII	1938.16 ± 58.62^d	2392.23 ± 206.01^d

ISSN: 1471-230X